Vivos (RDGL) Assets Growth (1y) (2011 - 2025)
Vivos (RDGL) Assets Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.06 Bn | 175.76 Bn | 6.27 Bn |
| 2 | Stryker | 128.66 Bn | 125.78 Bn | 3.81 Bn |
| 3 | Medtronic | 108.82 Bn | 99.60 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.43 Bn | 66.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.29 Bn | 44.61 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.37 Bn | 26.08 Bn | 1.98 Bn |
| 7 | Dexcom | 28.29 Bn | 27.18 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.31 Bn | 2.07 Bn |
| 10 | Vivos | 26.71 Mn | 25.15 Mn | -3,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -16.38% |
| Sep 30, 2025 | 84.45% |
| Jun 30, 2025 | 56.84% |
| Mar 31, 2025 | 138.86% |
| Dec 31, 2024 | 38.71% |
| Sep 30, 2024 | -20.57% |
| Jun 30, 2024 | -1.12% |
| Mar 31, 2024 | -5.43% |
| Dec 31, 2023 | -7.61% |
| Sep 30, 2023 | -23.44% |
| Jun 30, 2023 | 61.50% |
| Mar 31, 2023 | 11.76% |
| Dec 31, 2022 | 6.64% |
| Sep 30, 2022 | 0.12% |
| Jun 30, 2022 | -50.37% |
| Mar 31, 2022 | -48.08% |
| Dec 31, 2021 | 74.32% |
| Sep 30, 2021 | 3,429.68% |
| Jun 30, 2021 | 645.36% |
| Dec 31, 2020 | 2,036.94% |